Expression of c‐myc in altered hepatic foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phenobarbital

Publisher Website
Google Scholar
Abstract
Among the proto‐oncogenes examined by northern blot analysis, c‐myc, c‐Ha‐ras, c‐fos, and c‐raf‐1 have been reported to be activated in rat liver cell carcinomas. However, there are relatively few reports on proto‐oncogene expression in altered hepatic foci (a) early during hepatocarcinogenesis in the rat. In this study, diethylnitrosamine (a) at doses ranging from 10 to 200 mg/kg was used to initiate and phenobarbital (0.05%) to promote AHF in rats. AHF were detected by the presence of the marker enzymes glutathione s‐transferase, placental form (GST‐P); γ‐glutamyltranspeptidase (a); glucose‐6‐phosphatase (G6Pase); and canalicular ad‐enosine triphosphatase (a). Proto‐oncogene expression in individual AHF was investigated by in situ hybridization (a). ISH for the mRNAs of c‐Ha‐ras, c‐fos, and c‐raf‐1 revealed little or no expression in AHF. However, the levels of c‐myc mRNA were increased in about 10% of the AHF initiated by the highest dose of DEN (200 mg/kg). Thus, altered expression of proto‐oncogenes was not seen in AHF initiated by nonnecrogenic doses of DEN and promoted by phenobarbital. However, at the necrogenic dose of 200 mg/kg DEN, c‐myc expression was found mostly in AHF in which abnormal expression of GST‐P, GGT, G6Pase, and ATPase was also present, indicating that c‐myc expression is correlated with phenotypically greater complexity of the AHF, a characteristic of malignant hepatic neoplasms in the rat. © 1995 Wiley‐ Liss, Inc.